728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads

KraneShares MSCI All China Health Care ETF (NYSE: KURE) Lists on the New York Stock Exchange

THIS POST WAS ORIGINALLY PUBLISHED ON THIS SITE Click Here To Read Entire Article

NEW YORK, Feb. 2, 2018 /PRNewswire/ — Krane Funds Advisors, LLC, (“KraneShares”) a U.S. asset management firm known for its China focused KraneShares exchange traded funds (ETFs) and innovative China investment strategies, announced the launch of the KraneShares MSCI All China Health Care Index ETF (NYSE: KURE) listed on the NYSE. KURE tracks the performance of MSCI China All Shares Health Care 10/40 Index which includes publicly listed companies in Mainland China, Hong Kong and United States that are involved in the healthcare industry, specifically: patent and generic pharmaceuticals, hospital administration, biotechnology, medical equipment production, healthcare IT, and traditional Chinese medicine.

China currently has the fastest growing major healthcare market in the world with a five-year compound annual growth rate of 17%, compared to just 4% in the United States, and -2% in Japan1. In 2015 China surpassed Japan to become the second largest healthcare market globally, in terms of total healthcare expenditure, at $594 billion1. This number is projected to nearly double to $1.1 trillion by 20202. There is still opportunity for considerable growth in China’s healthcare sector with per capita healthcare spending at just $420, compared to an average of over $5,800 for the world’s top eight healthcare markets3.

“China’s aging population, rising incomes and increasing urbanization may provide a sustained catalyst for growth in China’s healthcare sector,” said Jonathan Krane, CEO of KraneShares. “We believe China’s competitive research and development environment and favorable government policies also make China’s healthcare sector particularly attractive.”

KURE measures the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard (GICS) as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.

About Krane Funds Advisors, LLC:

Krane Funds Advisors, LLC is the investment manager for KraneShares ETFs. Our suite of China focused ETFs provides investors with solutions to capture China’s importance as an essential element of a well-designed investment portfolio. We strive to provide innovative, first to market strategies that have been developed

About The Author

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *